Japan Hospice Holdings Inc.

TSE:7061.T

1407 (JPY) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q4
Revenue 2,955.9492,725.4162,650.0192,572.1362,404.382,245.3312,260.8592,123.9681,890.0661,619.4241,617.5541,581.291,449.1821,371.2111,328.8451,301.7651,181.6811,104.6051,141.1881,105.1341,000.708946.622896.177
Cost of Revenue 2,549.5832,289.6512,286.1072,012.051,915.7661,749.7741,748.1381,674.8681,510.1961,380.1551,305.4891,241.081,234.0181,119.6081,102.8021,044.775992.487916.629846.924824.564814.764717.634666.162
Gross Profit 406.366435.765363.912560.086488.614495.557512.721449.1379.87239.269312.065340.21215.164251.603226.043256.99189.194187.976294.264280.57185.944228.988230.015
Gross Profit Ratio 0.1370.160.1370.2180.2030.2210.2270.2110.2010.1480.1930.2150.1480.1830.170.1970.160.170.2580.2540.1860.2420.257
Reseach & Development Expenses 00000000000000000000000
General & Administrative Expenses 2017181818181922151213101114151514212323242020
Selling & Marketing Expenses 7486.21575.86474.41641.51179.76470.56770.96694.28379.30266.09868.9573.41986.482447473766364537259
SG&A 94.013103.21593.86492.41659.51197.76489.56792.966109.28391.30279.09878.9584.419100.482598987978687779279
Other Expenses -82.411-64.512-57.4970.9850.2421.66626.876-0.3060.17779.713-4.205-0.8684.44725.8291.8630.8751.2530.5170.2910.0440.63-4.681-64.311
Operating Expenses 176.424167.727151.361166.894132.228173.989144.409164.156170.191142.88114.295130.51126.161149.89391.094133.955136.139140.5134.496123.146105.911125.032147.421
Operating Income 229.942268.038212.551393.192356.386321.565368.311284.945209.67896.387197.77209.789.001101.709134.949123.03453.05647.473159.77157.42280.034103.95282.595
Operating Income Ratio 0.0780.0980.080.1530.1480.1430.1630.1340.1110.060.1220.1330.0610.0740.1020.0950.0450.0430.140.1420.080.110.092
Total Other Income Expenses Net -105.203-21.921-23.006-91.904-83.785-56.665-48.416-73.528-73.35720.307-60.906-51.601-45.704-22.476-41.38-40.95-35.871-34.244-28.947-26.953-25.725-32.124-26.948
Income Before Tax 124.739246.117189.545301.288272.601264.9319.895211.417136.321116.694136.864158.09943.29779.23393.56982.08417.18513.229130.823130.46954.30971.82855.647
Income Before Tax Ratio 0.0420.090.0720.1170.1130.1180.1410.10.0720.0720.0850.10.030.0580.070.0630.0150.0120.1150.1180.0540.0760.062
Income Tax Expense 51.76994.07366.55697.78981.767100.341117.9383.24258.99445.41560.21960.30820.44635.71948.40926.40515.7618.43229.26539.214-4.11125.16618.032
Net Income 72.97152.044122.989203.499190.834164.558194.456120.01268.98271.27976.64597.79222.8543.51445.16155.6781.4244.797101.55891.25558.41946.66237.614
Net Income Ratio 0.0250.0560.0460.0790.0790.0730.0860.0570.0360.0440.0470.0620.0160.0320.0340.0430.0010.0040.0890.0830.0580.0490.042
EPS 8.8118.7215.2825.3223.7420.4724.2414.978.68.99.612.282.885.535.816.950.250.6213.412.187.926.565.36
EPS Diluted 8.6818.1315.225.1523.5820.3324.0514.858.558.819.4912.122.835.435.656.860.250.5911.7112.17.756.485.36
EBITDA 358.586390.388326.731409.528371.965358.581410.528299.989225.196190.073207.532222.804107.417141.511150.781137.88368.27761.962174.03171.43895.333113.2497.102
EBITDA Ratio 0.1210.1430.1230.1590.1550.160.1820.1410.1190.1170.1280.1410.0740.1030.1130.1060.0580.0560.1520.1550.0950.120.108